國立虎尾科技大學 |

Chemotherapy and Immunotherapy in Urologic Oncology = A Guide for the Advanced Practice Provider /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Chemotherapy and Immunotherapy in Urologic Oncology/ edited by Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi.
其他題名:	A Guide for the Advanced Practice Provider /
其他作者:	Lizardi-Calvaresi, Anne E.
面頁冊數:	XIV, 307 p. 22 illus., 19 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Primary Care Medicine. -
電子資源:	https://doi.org/10.1007/978-3-030-52021-2
ISBN:	9783030520212

Chemotherapy and Immunotherapy in Urologic Oncology = A Guide for the Advanced Practice Provider /
Chemotherapy and Immunotherapy in Urologic OncologyA Guide for the Advanced Practice Provider /[electronic resource] :edited by Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi. - 1st ed. 2021. - XIV, 307 p. 22 illus., 19 illus. in color.online resource.

Introduction: Integration of APP into Urologic Oncology Practice -- Overview and Active Surveillance of Prostate Cancer -- Monitoring and Managing Men Following Initial Treatment of Prostate Cancer -- Radical Prostatectomy and Survivorship after Radical Prostatectomy -- Multimodal Treatment Plans in Prostate Cancer -- Radiotherapy for Prostate Cancer -- Androgen Deprivation Treatment -- Second Generation Androgen Targeted Agents -- Chemotherapy and prostate cancer -- Radiopharmaceuticals for Prostate Cancer -- Immunotherapy and Novel Agents on the Horizon for the Treatment of Prostate Cancer -- Bladder Cancer -- Intravesical Therapy for Non Muscle Invasive Urothelial Carcinoma -- Bladder Cancer: Muscle Invasive Disease -- Chemoradiation Bladder Preservation -- Metastatic Bladder Cancer and the Use of Cisplatin Chemotherapy -- Immunotherapy for Metastatic Urothelial Cancer -- Novel and experimental Strategies in the treatment of Metastatic Urothelial Carcinoma -- Upper Tract Urothelial Carcinoma -- Kidney Cancer and Its Treatment -- Targeted Therapies for Treatment of Metastatic Renal Cell Carcinoma -- Immune Therapies for Metastatic Kidney Cancer -- Novel Therapies for Renal Cell Carcinoma -- Testicular Cancer -- Penile Cancer.

This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book’s chapters offers a bulleted box of clinical pearls on the particular role of the APP. Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects. .

ISBN: 9783030520212

Standard No.: 10.1007/978-3-030-52021-2doiSubjects--Topical Terms:

673694
Primary Care Medicine.

LC Class. No.: RC870-923.2

Dewey Class. No.: 616.6

Chemotherapy and Immunotherapy in Urologic Oncology = A Guide for the Advanced Practice Provider /
LDR:03755nam a22003975i 4500 001 1049705
003 DE-He213
005 20210628084703.0
007 cr nn 008mamaa
008 220103s2021 gw | s |||| 0|eng d
020 $a 9783030520212 $9 978-3-030-52021-2
024 7 $a 10.1007/978-3-030-52021-2 $2 doi
035 $a 978-3-030-52021-2
050 4 $a RC870-923.2
050 4 $a RC875-899.5
072 7 $a MJS $2 bicssc
072 7 $a MED088000 $2 bisacsh
072 7 $a MJS $2 thema
082 0 4 $a 616.6 $2 23
245 1 0 $a Chemotherapy and Immunotherapy in Urologic Oncology $h [electronic resource] : $b A Guide for the Advanced Practice Provider / $c edited by Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a XIV, 307 p. 22 illus., 19 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Introduction: Integration of APP into Urologic Oncology Practice -- Overview and Active Surveillance of Prostate Cancer -- Monitoring and Managing Men Following Initial Treatment of Prostate Cancer -- Radical Prostatectomy and Survivorship after Radical Prostatectomy -- Multimodal Treatment Plans in Prostate Cancer -- Radiotherapy for Prostate Cancer -- Androgen Deprivation Treatment -- Second Generation Androgen Targeted Agents -- Chemotherapy and prostate cancer -- Radiopharmaceuticals for Prostate Cancer -- Immunotherapy and Novel Agents on the Horizon for the Treatment of Prostate Cancer -- Bladder Cancer -- Intravesical Therapy for Non Muscle Invasive Urothelial Carcinoma -- Bladder Cancer: Muscle Invasive Disease -- Chemoradiation Bladder Preservation -- Metastatic Bladder Cancer and the Use of Cisplatin Chemotherapy -- Immunotherapy for Metastatic Urothelial Cancer -- Novel and experimental Strategies in the treatment of Metastatic Urothelial Carcinoma -- Upper Tract Urothelial Carcinoma -- Kidney Cancer and Its Treatment -- Targeted Therapies for Treatment of Metastatic Renal Cell Carcinoma -- Immune Therapies for Metastatic Kidney Cancer -- Novel Therapies for Renal Cell Carcinoma -- Testicular Cancer -- Penile Cancer.
520 $a This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book’s chapters offers a bulleted box of clinical pearls on the particular role of the APP. Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects. .
650 2 4 $a Primary Care Medicine. $3 673694
650 2 4 $a General Practice / Family Medicine. $3 593966
650 2 4 $a Oncology. $3 593951
650 0 $a Primary care (Medicine). $3 1254357
650 0 $a General practice (Medicine). $3 1253458
650 0 $a Oncology . $3 1253469
650 0 $a Urology. $3 645258
700 1 $a Lizardi-Calvaresi, Anne E. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1353890
700 1 $a Lallas, Costas D. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1353889
700 1 $a Trabulsi, Edouard J. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1353888
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030520205
776 0 8 $i Printed edition: $z 9783030520229
856 4 0 $u https://doi.org/10.1007/978-3-030-52021-2
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)